The long-term objective of the proposed research is to develop new therapeutic drug regimens which could be effectively employed either alone or in combination for the treatment of acquired immunodeficiency syndrome (AIDS). To achieve this goal, a multidisciplinary effort has been initiated to synthesize a series of novel prodrugs of selected inhibitors of the enzyme reverse transcriptase of human immunodeficiency virus (HIV). The new analogs would be designed to achieve higher intracellular drug concentrations, to decrease bone marrow toxicity and to overcome the blood brain barrier. Based upon our encouraging results with isoleucine and retinoic acid esters of zidovudine (AZT), these prodrug moieties will also be linked to other 2', 3'-dideoxynucleosides (ddNs). Rational design of new analogs would include: (a) ddN esters of alpha-difluoremethylornithine (DFMO) or other inhibitors of ornithine decarboxylase in an attempt to deplete polyamine levels to overcome bone marrow toxicity and increase anti-HIV activity; (b) AZT ester of probenecid to increase intracellular uptake and to inhibit glucuronidation of AZT at the site of hepatic metabolism; and (c) dimers of ddNs with uridine (e.g. AZT-P-U) or ddN esters of orotic acid in an attempt to decrease bone marrow toxicity. A second major effort will be directed toward our finding that alpha-D- tocopherol succinate (ATS) increased the therapeutic efficacy of AZT significantly, and therefore, this combination will be explored with other ddNs (ddC, ddI, and d4T). The mechanism(s) involved in the synergistic increase in anti-HIV activity and decrease in bone marrow toxicity will be investigated. The physicochemical parameters such as partition coefficients and protein binding capacities of newly synthesized agents will be determined. Evaluation of intracellular uptake and antiviral activity of prodrugs will be carried out in vitro by employing HIV-infected cells such as peripheral blood lymphocytes (PBL), or lymphocytic (H9, MT4) and monocytic (U937) cell lines. Active agents resulting from this program will be studied in mice and rabbits for pharmacokinetic parameters to determine the extent and rate of entry of various prodrugs in the cerebrospinal fluid and brain tissue. The multidisciplinary approach of this application will allow maximum efficiency in the development of the most effective therapeutic regimens which can be used for the treatment of AIDS.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI025909-06
Application #
3139591
Study Section
Special Emphasis Panel (ARR (V2))
Project Start
1987-09-30
Project End
1994-05-31
Budget Start
1992-09-01
Budget End
1994-05-31
Support Year
6
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Tulane University
Department
Type
Schools of Medicine
DUNS #
City
New Orleans
State
LA
Country
United States
Zip Code
70118
Jaspan, Heather B; Robinson, James E; Amedee, Angela Martin et al. (2004) Amniotic fluid has higher relative levels of lentivirus-specific antibodies than plasma and can contain neutralizing antibodies. J Clin Virol 31:190-7
Plymale, D R; Comardelle, A M; Fermi, C D et al. (1999) Concentration-dependent differential induction of necrosis or apoptosis by HIV-1 lytic peptide 1. Peptides 20:1275-83
Plymale, D R; Tang, D S; Comardelle, A M et al. (1999) Both necrosis and apoptosis contribute to HIV-1-induced killing of CD4 cells. AIDS 13:1827-39
Gatti, P J; Choi, B; Haislip, A M et al. (1998) Inhibition of HIV type 1 production by hygromycin B. AIDS Res Hum Retroviruses 14:885-92
Choi, B; Gatti, P J; Haislip, A M et al. (1998) Role of potassium in human immunodeficiency virus production and cytopathic effects. Virology 247:189-99
Comardelle, A M; Norris, C H; Plymale, D R et al. (1997) A synthetic peptide corresponding to the carboxy terminus of human immunodeficiency virus type 1 transmembrane glycoprotein induces alterations in the ionic permeability of Xenopus laevis oocytes. AIDS Res Hum Retroviruses 13:1525-32
Garry, R F; Fermin, C D; Kohler, P F et al. (1996) Antibodies against retroviral proteins and nuclear antigens in a subset of idiopathic CD4+ T lymphocytopenia patients. AIDS Res Hum Retroviruses 12:931-40
Gogu, S R; Agrawal, K C (1996) The protective role of zinc and N-acetylcysteine in modulating zidovudine induced hematopoietic toxicity. Life Sci 59:1323-9
Voss, T G; Gatti, P J; Fermin, C D et al. (1996) Reduction of human immunodeficiency virus production and cytopathic effects by inhibitors of the Na+/K+/2Cl- cotransporter. Virology 219:291-4
Ulug, E T; Garry, R F; Bose Jr, H R (1996) Inhibition of Na+K+ATPase activity in membranes of Sindbis virus-infected chick cells. Virology 216:299-308

Showing the most recent 10 out of 21 publications